Douglas Krakower

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis
    Douglas S Krakower
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Curr HIV/AIDS Rep 12:127-38. 2015
  2. pmc Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges
    Douglas S Krakower
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Suite GB, Boston, MA, 02215 5501, USA
    Drugs 75:243-51. 2015
  3. pmc HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study
    Douglas Krakower
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, 110 Francis St, WLMOB, Suite GB, Boston, MA, 02215, USA
    AIDS Behav 18:1712-21. 2014
  4. pmc Limited Awareness and Low Immediate Uptake of Pre-Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site
    Douglas S Krakower
    Harvard Medical School, Boston, Massachusetts, United States of America
    PLoS ONE 7:e33119. 2012
  5. pmc Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications
    Douglas Krakower
    Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Curr HIV/AIDS Rep 8:241-8. 2011
  6. pmc What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review
    Douglas Krakower
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Ann Intern Med 157:490-7. 2012
  7. doi request reprint Sexual Behavior Patterns and PrEP Dosing Preferences in a Large Sample of North American Men Who Have Sex With Men
    Conor Stack
    Department of Medicine, Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA Department of Epidemiology, Harvard School of Public Health, Boston, MA Institute for Community Health Promotion, Brown University School of Public Health, Providence, RI The Fenway Institute, Fenway Health, Boston, MA Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA On Line Buddies, Cambridge, MA Department of Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, PA and Department of Psychology, University of Miami, Coral Gables, FL
    J Acquir Immune Defic Syndr 71:94-101. 2016
  8. pmc Engaging healthcare providers to implement HIV pre-exposure prophylaxis
    Douglas Krakower
    Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Curr Opin HIV AIDS 7:593-9. 2012
  9. doi request reprint State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United States
    Catherine E Oldenburg
    aDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts bDepartment of Sociomedical Sciences, Columbia Mailman School of Public Health, New York, USA cDivision of Infectious Diseases, Department of Internal Medicine, Beth Israel Deaconess Medical Center dOLB Research Institute, Online Buddies, Inc, Cambridge eThe Fenway Institute, Fenway Community Health fDepartment of Psychiatry, Harvard Medical School Massachusetts General Hospital gDepartment of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS 29:837-45. 2015
  10. doi request reprint Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress
    Kenneth H Mayer
    The Fenway Institute, Fenway Health, Boston, MA, USA
    J Int AIDS Soc 18:19980. 2015

Collaborators

Detail Information

Publications12

  1. pmc Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis
    Douglas S Krakower
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Curr HIV/AIDS Rep 12:127-38. 2015
    ..By contextualizing the most noteworthy recent findings regarding PEP and PrEP, this review seeks to inform the successful implementation of these promising prevention approaches. ..
  2. pmc Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges
    Douglas S Krakower
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Suite GB, Boston, MA, 02215 5501, USA
    Drugs 75:243-51. 2015
    ....
  3. pmc HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study
    Douglas Krakower
    Division of Infectious Diseases, Beth Israel Deaconess Medical Center, 110 Francis St, WLMOB, Suite GB, Boston, MA, 02215, USA
    AIDS Behav 18:1712-21. 2014
    ..Overall, participants reported limited prescribing intentions. Without interventions to address HIV providers' concerns, implementation of PrEP in HIV clinics may be limited. ..
  4. pmc Limited Awareness and Low Immediate Uptake of Pre-Exposure Prophylaxis among Men Who Have Sex with Men Using an Internet Social Networking Site
    Douglas S Krakower
    Harvard Medical School, Boston, Massachusetts, United States of America
    PLoS ONE 7:e33119. 2012
    ..Online surveys were conducted to assess PrEP awareness, interest and experience among at-risk MSM before and after iPrEx, and to determine demographic and behavioral factors associated with these measures...
  5. pmc Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications
    Douglas Krakower
    Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Curr HIV/AIDS Rep 8:241-8. 2011
    ..If future studies confirm the safety and efficacy of tenofovir gel and oral PrEP, successful implementation of these strategies could significantly impact the HIV epidemic...
  6. pmc What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review
    Douglas Krakower
    Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Ann Intern Med 157:490-7. 2012
    ..Issues related to cost and insurance coverage are also discussed. Recent data suggest that PrEP, combined with other prevention strategies, holds promise in helping to curtail the HIV epidemic...
  7. doi request reprint Sexual Behavior Patterns and PrEP Dosing Preferences in a Large Sample of North American Men Who Have Sex With Men
    Conor Stack
    Department of Medicine, Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA Department of Epidemiology, Harvard School of Public Health, Boston, MA Institute for Community Health Promotion, Brown University School of Public Health, Providence, RI The Fenway Institute, Fenway Health, Boston, MA Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA On Line Buddies, Cambridge, MA Department of Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, PA and Department of Psychology, University of Miami, Coral Gables, FL
    J Acquir Immune Defic Syndr 71:94-101. 2016
    ..Little is known about the acceptability of less than daily, intermittent PrEP regimens...
  8. pmc Engaging healthcare providers to implement HIV pre-exposure prophylaxis
    Douglas Krakower
    Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Curr Opin HIV AIDS 7:593-9. 2012
    ..Therefore it is critical to understand provider knowledge, practices, and attitudes towards PrEP prescribing, and to develop strategies for engaging and training providers to provide PrEP...
  9. doi request reprint State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United States
    Catherine E Oldenburg
    aDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts bDepartment of Sociomedical Sciences, Columbia Mailman School of Public Health, New York, USA cDivision of Infectious Diseases, Department of Internal Medicine, Beth Israel Deaconess Medical Center dOLB Research Institute, Online Buddies, Inc, Cambridge eThe Fenway Institute, Fenway Community Health fDepartment of Psychiatry, Harvard Medical School Massachusetts General Hospital gDepartment of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS 29:837-45. 2015
    ..However, few studies have examined structural stigma related to sexual minority status as a risk factor for HIV outcomes among MSM...
  10. doi request reprint Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress
    Kenneth H Mayer
    The Fenway Institute, Fenway Health, Boston, MA, USA
    J Int AIDS Soc 18:19980. 2015
    ....
  11. pmc The Promise of Antiretrovirals for HIV Prevention
    Charlene Flash
    Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Suite GB, Boston, MA, USA
    Curr Infect Dis Rep 14:185-93. 2012
    ..Ongoing research will help characterize the role for oral and topical formulations and help quantify potential benefits in sub-populations at risk for HIV acquisition...
  12. pmc Antiretroviral medication and HIV prevention: new steps forward and new questions
    Kenneth H Mayer
    Fenway Health and Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Ann Intern Med 156:312-4. 2012
    ..However, a substantial gap exists between current expenditures and unmet needs, which suggests that mobilization of political will is needed for this combination approach to be successful...